Jie Ni

Title: Jie Ni: Innovator in Pharmaceutical Development

Introduction

Jie Ni is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for capsid protein assembly. With a total of 3 patents to his name, his work is focused on addressing critical health issues, including those related to hepatitis B virus infections.

Latest Patents

Jie Ni's latest patents include innovative compounds that serve as capsid protein assembly inhibitors. One of his notable inventions is a pharmaceutical composition that includes a compound of formula I or II, which can be a stereoisomer, tautomer, geometrical isomer, solvate, active metabolite, hydrate, prodrug, or a pharmaceutically acceptable salt. This composition is designed for medical use in treating diseases that benefit from capsid protein assembly inhibition, particularly those caused by hepatitis B virus infection. Another patent focuses on a similar N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, emphasizing its pharmaceutical composition and medical applications.

Career Highlights

Jie Ni is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that address significant health challenges.

Collaborations

Jie Ni collaborates with esteemed colleagues in his field, including Yinsheng Zhang and Wangwei Ao. Their combined expertise contributes to the innovative research and development of pharmaceutical solutions.

Conclusion

Jie Ni's contributions to pharmaceutical innovation, particularly in the area of capsid protein assembly inhibitors, highlight his role as a key inventor in the industry. His ongoing work promises to make a significant impact on the treatment of diseases caused by hepatitis B virus infection.